Merck & Co

Merck & Co Debt/Market Cap

The Debt to Market Capitalization Ratio of Merck & Co (MRK) as of Nov 4, 2026 is 16.47 %. In the previous year, Debt to Market Capitalization Ratio was 12.32 % — a change of 33.74% (higher).

Debt/Market Cap

16.47 %

YoY

33.74%

Last updated:

Debt to Market Capitalization Ratio of Merck & Co is 2025 16.47 % . Debt to Market Capitalization Ratio of Merck & Co was 2024 12.32 % . It decreases by 33.74% higher compared to the previous year.

The Merck & Co Debt/Market Cap history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/Market Cap
Date
Debt/Market Cap
Jan 1, 2018
8.33 USD
Jan 1, 2019
8.74 USD
Jan 1, 2020
10.55 USD
Jan 1, 2021
10.98 USD
Jan 1, 2022
10.18 USD
Jan 1, 2023
11.63 USD
Jan 1, 2024
12.32 USD
Jan 1, 2025
16.47 USD
The Merck & Co Debt/Market Cap history
YEARDebt/Market CapYoY
16.47 %+33.74%
12.32 %+5.87%
11.63 %+14.22%
10.18 %-7.28%
10.98 %+4.12%
10.55 %+20.67%
8.74 %+4.91%
8.33 %+2.88%
8.10 %-1.74%
8.24 %-5.94%
8.76 %+23.40%
7.10 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Merck & Co Stock analysis

What does Merck & Co do? The company Merck & Co Inc has a long history. It was founded in 1891 by the German pharmacist Friedrich Jacob Merck and is now based in Kenilworth, New Jersey, USA. The company has evolved over time into a globally operating company in the pharmaceutical and chemical industry. Merck & Co Inc's business model is based on the development, production, and marketing of medicines and products for the healthcare industry. The company collaborates with other partners such as universities, other companies, and governments to achieve the best possible scientific progress. Research and development play a very important role in this. Merck is divided into three main areas: The Human Health division, which specializes in the development of prescription drugs and products to improve human health. The second division is Animal Health, which focuses on animal medicines and care products. The third division, Life Science (formerly MilliporeSigma), is dedicated to the development of products and services for biopharmaceutical research and production to facilitate the discovery and manufacturing of medicines. Merck & Co Inc. offers a wide range of products, ranging from prescription medicines to specialty chemicals. Some of the most well-known drugs include Januvia for the treatment of type 2 diabetes and Keytruda, an immuno-oncology drug used in the treatment of various types of cancer. Other well-known drugs from Merck & Co Inc. include Gardasil for the prevention of HPV infections, Propecia for the treatment of male pattern hair loss, and Zetia for the treatment of high cholesterol. The company is extremely innovative and has made significant advances in pharmaceutical research in recent decades. Merck & Co Inc. has won numerous awards over the years, including the "2018 Australian Financial Review Boss Most Innovative Companies Award" and the "2018 Global Energy Award for Technology Innovation". Merck & Co Inc. operates worldwide and has subsidiaries and partnerships in many countries. The company has about 69,000 employees and distributes its products in over 140 countries. Merck & Co Inc.'s products are typically prescription-only and prescribed by doctors and professionals. Overall, Merck & Co Inc. is a company with an impressive history that is now one of the leading companies in the pharmaceutical and chemical industry. Thanks to its innovation and its consistent focus on the needs of patients and healthcare professionals, it is able to successfully meet challenges in the healthcare industry and set new standards. Merck & Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merck & Co stock

Debt to Market Capitalization Ratio of Merck & Co is 16.47 % in 2025.

Debt to Market Capitalization Ratio of Merck & Co changed from 12.32 % to 16.47 %, representing a 33.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt to Market Capitalization Ratio Merck & Co since 2006 – with annual values, charts, and detailed analysis.

Debt/Market Cap compares total debt to the market value of equity. It provides a market-based view of financial leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt to Market Capitalization Ratio's Merck & Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Merck & Co

All Key Metrics — Merck & Co